Jennifer A Doudna
10% Owner; Director · 5 filings · Latest: Sep 1, 2026
JOHNSON & JOHNSON
Scribe Therapeutics, Inc.
Tempus AI, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
TEM | Jennifer A Doudna | Director | Sep 1, 2026 | Sale | $65.55 | 676 | $44.3K | 25,266 | |
TEM | JENNIFER DOUDNA | — | Sep 1, 2026 | Proposed Sale | $63.05 | 676 | $42.6K | — | |
TEM | Jennifer A Doudna | Director | Jun 25, 2026 | Sale | $55.00 | 2,673 | $147.0K | 25,942 | |
TEM | JENNIFER DOUDNA | — | Apr 15, 2026 | Proposed Sale | $49.53 | 3,348 | $165.8K | — | |
TEM | JENNIFER DOUDNA | — | Nov 11, 2025 | Proposed Sale | $71.78 | 3,852 | $276.5K | — | |
TEM | JENNIFER A DOUDNA | — | Jun 2, 2025 | Proposed Sale | $55.18 | 1,183 | $65.3K | — | |
TEM | JENNIFER A DOUDNA | — | Feb 14, 2025 | Proposed Sale | $83.75 | 11,253 | $942.4K | — | |
TEM | JENNIFER A DOUDNA | — | Dec 11, 2024 | Proposed Sale | $45.00 | 2,146 | $96.6K | — |